Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting
Comparação dos efeitos de sugamadex e neostigmina em náusea e vômito no pós-operatório
Özgür Yağ; an; Nilay Taş; ; Tuğ; çe Mutlu; Volkan Hancı;
Abstract
Keywords
Resumo
Palavras-chave
Referências
Kapur PA. The big "little problem". Anesth Analg. 1991;73:243-5.
Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992;77:162-84.
Kenny GN. Risk factors for postoperative nausea and vomiting. Anaesthesia. 1994;49:6-10.
Apfel CC, Greim CA, Haubitz I. A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand. 1998;42:495-501.
Apfel CC, Greim CA, Haubitz I. The discriminating power of a risk score for postoperative vomiting in adults undergoing various types of surgery. Acta Anaesthesiol Scand. 1998;42:502-9.
Figueredo E, Canosa L. Prophylactic ondansetron for postoperative emesis. Meta-analysis of its effectiveness in patients with previous history of postoperative nausea and vomiting. Acta Anaesthesiol Scand. 1999;43:637-44.
Tramer MR, Fuchs-Buder T. Omitting reversal of neuromuscular blockade: effect on postoperative nausea and vomiting and risk of residual paralysis: a systemic review. Br J Anaesth. 1999;82:379-86.
Jokela R, Koivuranta M. Tropisetron or droperidol in the prevention of postoperative nausea and vomiting. A comparative, randomised, double-blind study in women undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 1999;43:645-50.
de Boer HD, van Egmond J, van de Pol F. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. Br J Anaesth. 2006;96:201-6.
Gijsenbergh F, Ramael S, Houwing N. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103:695-703.
Sorgenfrei IF, Norrild K, Larsen PB. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology. 2006;104:667-74.
Mirakhur RK. Sugammadex in clinical practice. Anaesthesia. 2009;64:45-54.
Koyuncu O, Turhanoglu S. Comparison of sugammadex and conventional reversal on postoperative nausea and vomiting: a randomized, blinded trial. J Clin Anesth. 2015;27:51-6.
Apfel CC, Laara E, Koivuranta M. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology. 1999;91:693-700.
Gan TJ, Meyer TA, Apfel CC. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2007;105:1615-28.
Løvstad RZ, Thagaard KS, Berner NS. Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery. Acta Anaesthesiol Scand. 2001;45:495-500.
King MJ, Milazkiewicz R, Carli F, Deacock AR. Influence of neostigmine on postoperative vomiting. Br J Anaesth. 1988;61:403-6.
Ding Y, Fredman B, White PF. Use of mivacurium during laparoscopic surgery: effect of reversal drugs on postoperative recovery. Anesth Analg. 1994;78:450-4.
Ho KM, Ismail H, Lee KC. Use of intrathecal neostigmine as an adjunct to other spinal medications in perioperative and peripartum analgesia: a meta-analysis. Anaesth Intensive Care. 2005;33:41-53.
Cheng CR, Sessler DI, Apfel CC. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?. Anesth Analg. 2005;101:1349-55.
Hovorka J, Korttila K, Nelskylä K. Reversal of neuromuscular blockade with neostigmine has no effect on the incidence or severity of postoperative nausea and vomiting. Anesth Analg. 1997;85:1359-61.
Nelskylä K, Yli-Hankala A, Soikkeli A. Neostigmine with glycopyrrolate does not increase the incidence or severity of postoperative nausea and vomiting in outpatients undergoing gynaecological laparoscopy. Br J Anaesth. 1998;81:757-60.
Ledowski T, Falke L, Johnston F. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol. 2014;31:423-9.